Recticare Cloth
NDC Package 0496-0980-65
Package Information
Recticare (lidocaine and glycerin) cloths is when practical, cleanse the affected area with mild soap and warm water and rinse thoroghlygently apply wipe to the affected area by patting and then discardadults and children 12 years & older: apply up to 6 times daily - or after each bowel movementchildren under 12 years: consult a doctor. This formulation utilizes a cloth delivery system. Marketed by Ferndale Laboratories, Inc., this product is identified by NDC 0496-0980 and is authorized under FDA application M015.
Identification & Billing
- RxCUI: 1602013 - lidocaine HCl 5 % / glycerin 20 % Medicated Pad
- RxCUI: 1602013 - glycerin 200 MG/ML / lidocaine 43 MG/ML Medicated Pad
- RxCUI: 1602013 - glycerin 20 % / lidocaine 4.3 % (as lidocaine HCl 5 % ) Medicated Pad
- RxCUI: 1602013 - glycerin 20 % / lidocaine HCl 5 % Medicated Pad
- RxCUI: 1602019 - RectiCare 5 % / 20 % Medicated Pad
Clinical Specifications
- Allergens - [CS]
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Glycerol - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Local Anesthesia - [PE] (Physiologic Effect)
- Non-Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 0496 - Ferndale Laboratories, Inc.
- 0496-0980 - Recticare
- 0496-0980-65 - 12 POUCH in 1 CARTON / 6 g in 1 POUCH (0496-0980-76)
- 0496-0980 - Recticare
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0496-0980-65 identifies a specific commercial package of 12 pouch in 1 carton / 6 g in 1 pouch (0496-0980-76) of Recticare, a human over the counter drug labeled by Ferndale Laboratories, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This cloth is formulated for topical use and contains glycerin; lidocaine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ferndale Laboratories, Inc. on January 01, 2016. The current certification is valid through December 31, 2026.
How is this Ferndale Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00496098065. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.